Elsevier

Gender Medicine

Volume 6, Issue 1, April 2009, Pages 300-311
Gender Medicine

Effects of two estradiol regimens on anxiety and depressive behaviors and trophic effects in peripheral tissues in a rodent model

https://doi.org/10.1016/j.genm.2009.04.004Get rights and content

Abstract

Background: With aging and menopause, which are associated with decreases in ovarian steroids such as 17β-estradiol (E2), women might experience negative psychological symptoms, including anxiety and depression. Some women use E2-based therapies to alleviate these symptoms, but E2 has been associated with trophic effects that might increase vulnerability to some steroid-sensitive cancers, such as breast cancer, in both premenopausal and postmenopausal women.

Objective: This study investigated the relationships between the possible beneficial effects of E2 on anxiety and depressive behaviors concurrent with trophic effects using an animal model of E2 decline and replacement.

Methods: Dose-dependent effects of E2 on affective, sexual, and motor behavior of young adult rats were studied. Ovariectomized (OVX) rats were administered the chemical carcinogen 7,12-dimethylbenz(a) anthracene (DMBA) 1.25 mg or inactive vehicle (vegetable oil; control) by gavage. E2 (0.03 or 0.09 mg/kg) or vehicle was administered subcutaneously 44 to 48 hours before assessments of anxiety (light—dark transition), depression (forced swim test), sexual (lordosis), and motor (activity monitor) behaviors. Fourteen weeks after carcinogen exposure, E2 concentrations in plasma and brain regions (cortex, hippocampus, and hypothalamus) were determined. Incidences and numbers of tumors and uterine weight were analyzed.

Results: Administration of E2 (0.09 mg/kg) was associated with significant increases in antianxiety-like behavior in the light—dark transition task, antidepressant-like behavior in the forced swim test, and physiologic circulating and central E2 concentrations compared with E2 (0.03 mg/kg) and vehicle. Compared with vehicle, E2 (0.9 > 0.3 mg/kg) was associated with significant increases in lordosis and uterine weight. Administration of DMBA was associated with significant increases in the incidences and numbers of tumors; this effect was augmented by E2administration.

Conclusions: Based on the findings in this rat model, the hypothesis that E2 may be effective in reducing anxiety and depressive behaviors and enhance sexual behavior in OVX rats, concurrent with trophic effects in the periphery, was supported. Moderate physiologic levels of E2 might have beneficial effects on affective and sexual behaviors in female rodents, but regimens including E2 might increase tumorigenic capacity.

References (65)

  • D Razavi et al.

    Psychosocial correlates of oestrogen and progesterone receptors in breast cancer

    Lancet

    (1990)
  • JA Gustafsson

    What pharmacologists can learn from recent advances in estrogen signalling

    Trends Pharmacol Sci

    (2003)
  • DB Imwalle et al.

    Lack of functional estrogen receptor beta influences anxiety behavior and serotonin content in female mice

    Physiol Behav

    (2005)
  • CA Mazzucco et al.

    ERalpha, but not ERbeta, mediates the expression of sexual behavior in the female rat

    Behav Brain Res

    (2008)
  • LA Galea

    Gonadal hormone modulation of neurogenesis in the dentate gyrus of adult male and female rodents

    Brain Res Rev

    (2008)
  • M Wallace et al.

    Ovariectomized rats show decreased recognition memory and spine density in the hippocampus and prefrontal cortex

    Brain Res

    (2006)
  • AM Miniño et al.

    Deaths: Final data for 2004

    Natl Vital Stat Rep

    (2007)
  • A Henriques et al.
  • PR Rapp et al.

    Cyclic estrogen replacement improves cognitive function in aged ovariectomized rhesus monkeys

    J Neurosci

    (2003)
  • JE Rossouw et al.

    Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial

    JAMA

    (2002)
  • BB Sherwin

    The critical period hypothesis: Can it explain discrepancies in the oestrogen-cognition literature?

    J Neuroendocrinol

    (2007)
  • SA Shumaker et al.

    Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial

    JAMA

    (2003)
  • M Clemons et al.

    Estrogen and the risk of breast cancer [published correction appears in N Engl J Med. 2001;344:1804]

    N Engl J Med

    (2001)
  • BS Hulka

    Epidemiology of susceptibility to breast cancer

    Prog Clin Biol Res

    (1996)
  • M Lambe et al.

    Parity, age at first and last birth, and risk of breast cancer: A population-based study in Sweden

    Breast Cancer Res Treat

    (1996)
  • MP Madigan et al.

    Proportion of breast cancer cases in the United States explained by well-established risk factors

    J Natl Cancer Inst

    (1995)
  • JM Ramon et al.

    Age at first full-term pregnancy, lactation and parity and risk of breast cancer: A case-control study in Spain

    Eur J Epidemiol

    (1996)
  • HV Thomas et al.

    A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey

    Br J Cancer

    (1997)
  • JA Cauley et al.

    Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer

    Ann Intern Med

    (1999)
  • SE Hankinson et al.

    Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women

    J Natl Cancer Inst

    (1998)
  • PG Toniolo et al.

    A prospective study of endogenous estrogens and breast cancer in postmenopausal women

    J Natl Cancer Inst

    (1995)
  • C Schairer et al.

    Breast cancer risk associated with gynecologic surgery and indications for such surgery

    Int J Cancer

    (1997)
  • Cited by (42)

    • Ventral tegmental area GABAergic neurons induce anxiety-like behaviors and promote palatable food intake

      2020, Neuropharmacology
      Citation Excerpt :

      Sex hormones and their interaction with stress hormones play an important role in the development of stress-related disorders (Galea et al., 2014; Hillerer et al., 2019). Compelling evidence from various studies have demonstrated estrogen effects on anxiety and anxiety-like behaviors in both rodents and humans (Furuta et al., 2013; Pigott, 2003; Rapkin et al., 2002; Walf and Frye, 2007a, 2007b, 2009). In female rats, decreased anxiety-like behaviors are observed during pro-estrus when estrogen levels are high, and exogenous administration of estrogen shows anxiolytic effects on ovariectomized rats (Walf and Frye, 2007a, 2007b, 2009).

    View all citing articles on Scopus
    View full text